The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines...
Between the global COVID-19 pandemic, the associated economic downturn and widespread protests over racism, it’s difficult for everyone. Many people are struggling, consumed with anxiety and stress, finding ourselves unable to sleep or focus. As a developmental...
On the way of building the evidence base for national, state, and local policies that can advance racial equity in health and well-being in the US, the Robert Wood Johnson Foundation is now welcoming applications to its Policies for Action: Public Policy Research to...
As states across the country rush to curb the surge in coronavirus cases, once again the safest place for anyone to be is home. But for victims of domestic violence, home is far from a safe haven. The coronavirus has led to a surge in domestic violence, leaving...
Doctors and experts warn of another potential problem from the Covid-19 pandemic . This lurking problem is in the form of long-term health problems that may be experienced by patients who have been infected with the corona virus. Reynold Panettieri, Professor of...
